East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort

• Authors: AKIYAMA E.; VAN AELST L.N.L.; ARRIGO M.; LASSUS J.; MIRO O.; CELUTKIENE J.; CHOI D.J.; COHEN-SOLAL A..; ISHIHARA S.; KAJIMOTO K.; LARIBI S.; MAGGIONI A.P.; MOTIEJUNAITE J.; MUELLER C.; PAŘENICA Jiří; PARK J.J.; SATO N.; ŠPINAR Jindřich; ZHANG J.; ZHANG Y.H.; KIMURA K.; TAMURA K.; GAYAT E.; MEBAZAA A.
• Year of publication: 2018
• Type: Article in Periodical
• Magazine / Source: European Journal of heart Failure
• MU Faculty or unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.1002/ejhf.1152
• Keywords: acute heart failure
• Description: Acute heart failure (AHF) is a major health problem worldwide and trials to assess novel therapies are increasingly global, as a means to reduce costs, expedite timelines, provide broad applicability, and satisfy regulatory authorities.The significant geographic differences in patient characteristics, outcomes, and treatment effect may affect trial results and raise important questions about generalizability of the results to a broader population.